Heyd R, Strassmann G, Kirchner J, Schopohl B, Böttcher H D
Abteilung für Strahlentherapie und Onkologie, J.-W.-Goethe-Universität, Frankfurt a. M.
Strahlenther Onkol. 1996 Oct;172(10):543-52.
Following total hip arthroplasty high-grade heterotopic ossification occurs with a range of 0.5 to 27%. Local postoperative hip irradiation using different dosage and fractionation schedules reduces the incidence in high-risk cases on an average of 8%. The present retrospective study compares results after conventionally fractionated and high-dose radiotherapy.
A total of 50 hips (46 patients) from 2 different risk groups had complete follow-up. In group I (40 hips [80.0%]) radiotherapy was indicated after surgical excision of pre-existing high-grade heterotopic ossification, in group II (10 hips [20.0%]) for several risk factors (contralateral heterotopic ossification [n = 7], hypertrophic osteoarthritis [n = 2], spondylosis hyperostotica [n = 1]). In 28/50 cases (56.0%) conventionally fractionated irradiation with total doses ranging from 12.0 to 20.0 Gy was given, in 22/50 hips (44.0%) a high-dose irradiation consisting of 10.0 Gy given in 2 fractions on each of the first 2 postoperative days was applied. After a minimal observation period of 6 months (median: 22 months, range: 6 to 56 months) roentgenograms were analysed using a modified Brooker score.
At follow-up, 2 hips in group I had recurrence of high-grade heterotopic ossification with the stages IIIA and IVB. In 1 case radiotherapy was interrupted after 3 x 2.0 Gy due to sepsis (IIIA), in the other case ectopic bone recurred from bony islands which layed outside the radiation portal (IVB). In group II, 9 patients had stage 0 and 1 patient stage IA. Statistical analysis using the Wilcoxon test showed a highly significant reduction of the amount of pre-existing heterotopic ossification (p < 0.0001) for both fractionation schedules. The comparison of both fractionation groups with the Whitney-Mann-U-test (p = 0.92) showed no statistical significant difference.
The data about the high therapeutic efficacy of postoperative radiotherapy for prevention of heterotopic ossification were confirmed. Both fractionation schedules led to a sufficient reduction of high-grade heterotopic ossification in the 2 treated risk groups.
全髋关节置换术后,严重的异位骨化发生率为0.5%至27%。术后对髋关节进行局部放疗,采用不同的剂量和分割方案,可使高危病例的发生率平均降低8%。本回顾性研究比较了常规分割放疗和高剂量放疗的效果。
来自2个不同风险组的50例髋关节(46例患者)获得了完整的随访。在第一组(40例髋关节[80.0%])中,在手术切除已存在的严重异位骨化后进行放疗;在第二组(10例髋关节[20.0%])中,由于多种风险因素(对侧异位骨化[n = 7]、肥厚性骨关节炎[n = 2]、脊柱骨质增生[n = 1])而进行放疗。50例中有28例(56.0%)采用常规分割放疗,总剂量为12.0至20.0 Gy;22例髋关节(44.0%)采用高剂量放疗,即在术后头2天每天分2次给予10.0 Gy。在最短观察期6个月(中位数:22个月,范围:6至56个月)后,使用改良的布鲁克评分分析X线片。
随访时,第一组有2例髋关节出现严重异位骨化复发,分别为IIIA期和IVB期。1例因败血症在3×2.0 Gy后中断放疗(IIIA期),另1例异位骨从放疗野之外的骨岛复发(IVB期)。在第二组中,9例患者为0期,1例为IA期。使用威尔科克森检验进行统计分析显示,两种分割方案均可使已存在的异位骨化量显著减少(p < 0.0001)。采用惠特尼 - 曼 - U检验对两组分割方案进行比较(p = 0.92),未显示出统计学显著差异。
术后放疗预防异位骨化具有高治疗效果的数据得到了证实。两种分割方案均能使两个治疗风险组中的严重异位骨化充分减少。